JPRN-UMIN000004177招募中未知
Randomized Evaluation of Paclitaxel-eluting versus Everolimus-eluting stent Trial - Rapeet study
Division of Cardiovascular Medicine, Wakayama Medical University0 个研究点目标入组 800 人开始时间: 2010年9月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •No candiated for drug-eluing stent implantation
研究者
相似试验
进行中（未招募）
不适用
Breast cancer studyHer-2 negative metastatic or locally advanced inoperable breast cancerMedDRA version: 17.0Level: PTClassification code 10006202Term: Breast cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-018025-73-DEGMIHO mbH
进行中（未招募）
1 期
A randomised phase 2 study of paclitaxel with or without GSK1120212 in advanced wt BRAF melanoma - Paclitaxel +/- GSK1120212 in MelanomaEUCTR2011-002545-35-GBniversity of Oxford111
进行中（未招募）
1 期
A randomised phase 2 study of paclitaxel with or without GSK1120212 or pazopanib in advanced wt BRAF melanoma - Paclitaxel +/- GSK1120212 or pazopanib in MelanomaEUCTR2011-002545-35-DEniversity of Oxford138
已完成
不适用
A multicenter randomized comparison of paclitaxel-coated balloon with plain balloon angioplasty in patients withsmall vessel diseaseJPRN-UMIN000026760ipro Corporation135
尚未招募
3 期
A study to compare weekly Paclitaxel injection with best supportive care in patients with lung cancerCTRI/2018/04/013507Tata Memorial Hospital